 Carcinoma, Endometrioid
"Carcinoma, Endometrioid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.
| Descriptor ID |
D018269
|
| MeSH Number(s) |
C04.557.470.200.025.240 C04.588.945.418.948.585.124 C13.351.500.056.630.705.331 C13.351.937.418.685.331 C13.351.937.418.875.200.124 C19.391.630.705.331
|
| Concept/Terms |
Carcinoma, Endometrioid- Carcinoma, Endometrioid
- Carcinomas, Endometrioid
- Endometrioid Carcinoma
- Endometrioid Carcinomas
Adenocarcinoma, Endometrioid- Adenocarcinoma, Endometrioid
- Adenocarcinomas, Endometrioid
- Endometrioid Adenocarcinomas
- Endometrioid Adenocarcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Endometrioid".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Endometrioid [C04.557.470.200.025.240]
- Neoplasms by Site [C04.588]
- Urogenital Neoplasms [C04.588.945]
- Genital Neoplasms, Female [C04.588.945.418]
- Uterine Neoplasms [C04.588.945.418.948]
- Endometrial Neoplasms [C04.588.945.418.948.585]
- Carcinoma, Endometrioid [C04.588.945.418.948.585.124]
- Female Urogenital Diseases and Pregnancy Complications [C13]
- Female Urogenital Diseases [C13.351]
- Genital Diseases, Female [C13.351.500]
- Adnexal Diseases [C13.351.500.056]
- Ovarian Diseases [C13.351.500.056.630]
- Ovarian Neoplasms [C13.351.500.056.630.705]
- Carcinoma, Endometrioid [C13.351.500.056.630.705.331]
- Urogenital Neoplasms [C13.351.937]
- Genital Neoplasms, Female [C13.351.937.418]
- Ovarian Neoplasms [C13.351.937.418.685]
- Carcinoma, Endometrioid [C13.351.937.418.685.331]
- Uterine Neoplasms [C13.351.937.418.875]
- Endometrial Neoplasms [C13.351.937.418.875.200]
- Carcinoma, Endometrioid [C13.351.937.418.875.200.124]
- Endocrine System Diseases [C19]
- Gonadal Disorders [C19.391]
- Ovarian Diseases [C19.391.630]
- Ovarian Neoplasms [C19.391.630.705]
- Carcinoma, Endometrioid [C19.391.630.705.331]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Endometrioid".
This graph shows the total number of publications written about "Carcinoma, Endometrioid" by people in this website by year, and whether "Carcinoma, Endometrioid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 2001 | 0 | 2 | 2 | | 2003 | 0 | 1 | 1 | | 2004 | 1 | 0 | 1 | | 2007 | 0 | 1 | 1 | | 2009 | 1 | 1 | 2 | | 2010 | 0 | 1 | 1 | | 2012 | 0 | 2 | 2 | | 2015 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2017 | 3 | 0 | 3 | | 2018 | 2 | 0 | 2 | | 2019 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Endometrioid" by people in Profiles.
-
Tatebe K, Hasan Y, Son CH. Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors. Gynecol Oncol. 2019 12; 155(3):429-435.
-
Matsuo K, Cripe JC, Kurnit KC, Kaneda M, Garneau AS, Glaser GE, Nizam A, Schillinger RM, Kuznicki ML, Yabuno A, Yanai S, Garofalo DM, Suzuki J, St Laurent JD, Yen TT, Liu AY, Shida M, Kakuda M, Oishi T, Nishio S, Marcus JZ, Adachi S, Kurokawa T, Ross MS, Horowitz MP, Johnson MS, Kim MK, Melamed A, Machado KK, Yoshihara K, Yoshida Y, Enomoto T, Ushijima K, Satoh S, Ueda Y, Mikami M, Rimel BJ, Stone RL, Growdon WB, Okamoto A, Guntupalli SR, Hasegawa K, Shahzad MMK, Im DD, Frimer M, Gostout BS, Ueland FR, Nagao S, Soliman PT, Thaker PH, Wright JD, Roman LD. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer. Gynecol Oncol. 2019 10; 155(1):39-50.
-
Chapel DB, Patil SA, Plagov A, Puranik R, Mendybaeva A, Steinhardt G, Wanjari P, Lastra RR, Kadri S, Segal JP, Ritterhouse LL. Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma. Mod Pathol. 2019 10; 32(10):1508-1520.
-
Bennett JA, Pesci A, Morales-Oyarvide V, Da Silva A, Nardi V, Oliva E. Incidence of Mismatch Repair Protein Deficiency and Associated Clinicopathologic Features in a Cohort of 104 Ovarian Endometrioid Carcinomas. Am J Surg Pathol. 2019 02; 43(2):235-243.
-
Crumley S, Kurnit K, Hudgens C, Fellman B, Tetzlaff MT, Broaddus R. Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes. Mod Pathol. 2019 03; 32(3):396-404.
-
Chapel DB, Yamada SD, Cowan M, Lastra RR. Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens. Gynecol Oncol. 2018 06; 149(3):570-574.
-
Johnson DN, Barroeta JE, Antic T, Lastra RR. Cytomorphologic features of metastatic endometrioid carcinoma by fine needle aspiration. Diagn Cytopathol. 2018 Feb; 46(2):105-110.
-
Bishop EA, Java JJ, Moore KN, Spirtos NM, Pearl ML, Zivanovic O, Kushner DM, Backes F, Hamilton CA, Geller MA, Hurteau J, Mathews C, Wenham RM, Ramirez PT, Zweizig S, Walker JL. Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study. Am J Obstet Gynecol. 2018 01; 218(1):109.e1-109.e11.
-
Reyes HD, Miecznikowski J, Gonzalez-Bosquet J, Devor EJ, Zhang Y, Thiel KW, Samuelson MI, McDonald M, Stephan JM, Hanjani P, Guntupalli S, Tewari KS, Backes F, Ramirez N, Fleming GF, Filiaci V, Birrer MJ, Leslie KK. High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study. Gynecol Oncol. 2017 08; 146(2):247-253.
-
Kurnit KC, Kim GN, Fellman BM, Urbauer DL, Mills GB, Zhang W, Broaddus RR. CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence. Mod Pathol. 2017 07; 30(7):1032-1041.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|